AIDS Care logo Routledge, part of the Taylor & Francis Group logo

Publisher: Routledge, part of the Taylor & Francis Group

More about this publication?
Related content
Volume 16, Number 5, July 2004

< previous issue | all issues | next issue >

AIDS Impact
pp. 547-549(3)
Authors: F. van den Boom; L. Sherr

Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe
pp. 550-557(8)
Authors: E. Florence; W. Schrooten; C. Dreezen; V. Gordillo; L. Nilsson Schönnesson; D. Asboe; G. Koitz; R. Colebunders

Factors associated with Efavirenz discontinuation in a large community-based sample of patients
pp. 558-564(7)
Authors: B. Spire; P. Carrieri; M.-a. Garzot; M. L'henaff; Y. Obadia

Recruiting London gay men into an HIV vaccine trial: Is it feasible?
pp. 565-571(7)
Authors: L. Sherr; G. Bolding; J. Elford

Outcomes and lessons from a pilot RCT of a community-based HIV prevention multi-session group intervention for gay men
pp. 581-585(5)
Authors: R. Harding; J. Bensley; N. Corrigan; L. Franks; J. Stratman; Z. Waller; J. Warner

Behavioural responses of South African youth to the HIV/AIDS epidemic: A nationwide survey
pp. 605-618(14)
Authors: L. C. Simbayi; J. Chauveau; O. Shisana

Opinions toward pain management and palliative care: Comparison between HIV specialists and oncologists
pp. 619-627(9)
Authors: P. Peretti-watel; M. K. Bendiane; A. Galinier; J. M. Lapiana; R. Favre; H. Pegliasco; Y. Obadia

Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study
pp. 628-640(13)
Authors: R. L. Klitzman; S. B. Kirshenbaum; B. Dodge; R. H. Remien; A. A. Ehrhardt; M. O. Johnson; L. E. Kittel; S. Daya; S. F. Morin; J. Kelly; M. Lightfoot; M. J. Rotheram-borus

Families affected by HIV: Parents' and children's characteristics and disclosure to the children
pp. 641-648(8)
Authors: C. Nöstlinger; T. Jonckheer; E. de Belder; E. van Wijngaerden; C. Wylock; J. Pelgrom; R. Colebunders

Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment
pp. 649-661(13)
Authors: M. Préau; C. Leport; D. Salmon-ceron; P. Carrieri; H. Portier; G. Chene; B. Spire; P. Choutet; F. Raffi; M. Morin

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page